TRPC6 mRNA levels in the blood cells [15,16] are specifically reduced in patients with AD and moderate cognitive impairment as well as in AD patient-specific induced pluripotent stem cells (iPSCs) [17]. This evidence concerns the gene TRPC6 and Alzheimer disease.